[1]夏 雪,顾 明.急性冠脉综合征患者血清Gal-3浓度与病变程度及肌钙蛋白的相关性[J].医学信息,2021,34(01):116-118,122.[doi:10.3969/j.issn.1006-1959.2021.01.030]
　XIA Xue,GU Ming.Correlation of Serum Gal-3 Concentration with Disease Degree and Troponin in Patients with Acute Coronary Syndrome[J].Medical Information,2021,34(01):116-118,122.[doi:10.3969/j.issn.1006-1959.2021.01.030]
点击复制

急性冠脉综合征患者血清Gal-3浓度与病变程度及肌钙蛋白的相关性()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年01期
页码:
116-118,122
栏目:
论著
出版日期:
2021-01-01

文章信息/Info

Title:
Correlation of Serum Gal-3 Concentration with Disease Degree and Troponin in Patients with Acute Coronary Syndrome
文章编号:
1006-1959（2021）01-0116-04
作者:
夏 雪; 顾 明
（1.北华大学，吉林 吉林 132013； 2.北华大学附属医院心血管内科三疗区，吉林 吉林 132011）
Author(s):
XIA Xue; GU Ming
(1.Beihua University,Jilin 132013,Jilin,China; 2.The Third Treatment Zone of the Department of Cardiovascular Medicine,Affiliated Hospital of Beihua University, Jilin 132011,Jilin,China)
关键词:
半乳糖凝集素-3; 急性冠脉综合征; 炎症反应; 肌钙蛋白Ⅰ
Keywords:
Galectin-3; Acute coronary syndrome; Inflammatory response; TroponinⅠ
分类号:
R543.3+1
DOI:
10.3969/j.issn.1006-1959.2021.01.030
文献标志码:
A
摘要:
目的 探讨急性冠脉综合征（ACS）患者血清半乳糖凝集素3（Gal-3）与冠状动脉病变程度、肌钙蛋白的相关性，为尽早判断ACS 的危险程度，并给予相应治疗提供一定的实验室依据。方法 收集2018年9月~2020年6月于北华大学住院行冠脉造影确诊的ACS患者60例，收集24例行冠脉造影正常的非ACS患者作为对照组；入选病例均采集一般临床资料 ，均检测血清Gal-3及血清cTnⅠ，分析ACS患者血清Gal-3与冠脉病变程度及肌钙蛋白的相关性。结果 ACS组血清Gal-3水平高于对照组（P＜0.01）；吸烟率、体重指数（BMI）、糖尿病患病率、高血压患病率、血肌酐水平高于对照组，左心室射血分数低于对照组（P＜0.05）；血清Gal-3水平随病变血管数的增加而增加，不同病变血管数比较，差异有统计学意义（P＜0.01）；cTnⅠ+患者血清Gal-3水平高于cTnⅠ-患者[16.85（11.46，20.62）vs 7.73（4.89，10.45），P＜0.01]。在cTnⅠ+患者中，cTnⅠ浓度与血清Gal-3水平呈正相关（r=0.910，P＜0.01）。结论 ACS患者血清中Gal-3与病变严重程度及cTnⅠ浓度呈正相关，可以结合二者水平，作为筛选高危患者的指标之一。
Abstract:
Objective This study intends to investigate the relationship between serum galectin-3 (Gal-3) and the degree of coronary artery disease and troponin in patients with acute coronary syndrome (ACS), in order to determine the risk of ACS as soon as possible,and provide certain laboratory basis for corresponding treatment.Methods A total of 60 patients with ACS who were hospitalized at Beihua University and received coronary angiography from September 2018 to June 2020 were collected. 24 non-ACS patients with normal coronary angiography were collected as the control group; general clinical data were collected from the selected cases , Both serum Gal-3 and serum cTnⅠ were detected, and the correlation between serum Gal-3 and coronary artery disease degree and troponin in ACS patients was analyzed.Results Serum Gal-3 levels in the ACS group were higher than those in the control group (P<0.01); smoking rate, body mass index (BMI), prevalence of diabetes, prevalence of hypertension, blood creatinine levels were higher than those in the control group,the left ventricular ejection fraction was lower than that of the control group (P＜0.05);The level of serum Gal-3 increased with the increase of the number of diseased blood vessels,the difference of the number of different diseased blood vessels was statistically significant (P<0.01);Serum Gal-3 levels of cTnⅠ+ patients were higher than those of cTnⅠ- patients [16.85 (11.46, 20.62) vs 7.73 (4.89, 10.45),P<0.01]. In cTnI+ patients, the concentration of cTnI was positively correlated with serum Gal-3 level (r=0.910,P<0.01). Conclusion Serum Gal-3 in ACS patients is positively correlated with the severity of the lesion and the concentration of cTnI. The two levels can be combined as one of the indicators for screening high-risk patients.

参考文献/References:

[1]王猛,曾莉容,张弢.非ST段抬高型急性冠状动脉综合征hs-CRP、Lp(a)、CysC及ApoA与GRACE评分相关性研究[J].蚌埠医学院学报,2017,42(6):728-731. [2]徐晓晓,贾如意,王涛,等.半乳糖凝集素-3、可溶性基质溶素-2检测对心力衰竭诊断的相关性研究[J].中国循环杂志,2016,31(9):866-869. [3]徐晓晓,贾如意,王涛.半乳糖凝集素-3与心力衰竭的研究进展[J].中国循环杂志,2016,31(10):1034-1036. [4]李高楼,朱开功,杜庆钼.益气通脉汤对冠心病心绞痛病人机体Gal-3,ESM-1和Omentin-1水平的影响[J].中西医结合心脑血管病杂志,2016,14(23):2724-2727. [5]Zhong X,Qian X,Chen G,et al.The role of galectin-3 in heart failure and cardiovascular disease[J].Clin Exp Pharmacol Physiol,2019,46(3):197-203. [6]叶莎,王春亚,潘龙飞,等.半乳糖凝集素3及微量白蛋白尿与高血压患者左室肥厚的关系研究[J].中国循证心血管医学杂志,2019,11(7):814-817. [7]王宁,徐会圃.半乳糖凝集素-3与急性冠脉综合征预后相关性的研究进展[J].临床心血管病杂志,2019,35(1):88-91. [8]屈建新,邢冬梅,刘新灿.半乳糖凝集素-3在心肌纤维化相关心血管疾病中的研究进展[J].心血管病学进展,2019,40(4):605-608. [9]Jones DA,Rathod KS,Williamson A,et al.The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction[J].Int J Cardiol,2018,266(1):1-6. [10]Besler C,Lang D,Urban D,et al.Plasma and cardiac galectin-3 in patients with heart failure reflects both inflammation and fibrosis:implications for its use as a biomarker[J].Circ Heart Fail,2017,10(3):e003804. [11]Mosleh W,Chaudhari MR,Sonkawade S,et al.The therapeutic potential of blocking galectin-3 expression in acute myocardial infarction and mitigating inflammation of infarct region:a clinical outcome-based translational study[J].Biomark Insights,2018(13):1177271918771969. [12]Falcone C,Lucibello S,Mazzucchelli I,et al.Galectin-3 plasma levels and coronary artery disease:a new possible biomarker of acute coronary syndrome[J].Int J Immunopathol Pharmacol,2011,24(4):905-913. [13]Lee YJ,Koh YS,Park HE,et al.Spatial and temporal expression, and statin responsiveness of galectin-1 and galectin-3 in murine atherosclerosis[J].Korean Circ J,2013,43(4):223-230. [14]Mackinnon AC,Liu X,Hadoke PW,et al.Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice[J].Glycobiology,2013,23(6):654-663. [15]Kang Q,Li X,Yang M,et al.Galectin-3 in patients with coronary heart disease and atrial fibrillation[J].Clin Chim Acta,2018(478):166-170. [16]李玉芹,李会强.肌钙蛋白I的检测方法及研究进展[J].哈尔滨医药,2013,33(3):231-232. [17]葛均波,徐永健.内科学[M].北京:人民卫生出版社,2013:248. [18]Fuchs S,Kornowski R,Mehran R,et al.Prognostic value of cardiactroponin I levels following catheter-based coronary interventions[J].Am J Cardiol,2000(85):1077-1082.

相似文献/References:

[1]赵殿儒,祁景蕊.不同剂量瑞舒伐他汀对急性冠脉综合征患者心功能和炎症因子的影响[J].医学信息,2019,32(01):148.[doi:10.3969/j.issn.1006-1959.2019.01.046]
　ZHAO Dian-ru,YAN Jing-rui.Effects of Different Doses of Rosuvastatin on Cardiac Function and Inflammatory Factors in Patients with Acute Coronary Syndrome[J].Medical Information,2019,32(01):148.[doi:10.3969/j.issn.1006-1959.2019.01.046]
[2]镡子鸣,叶怀阔,任长杰.超敏C反应蛋白及妊娠相关血浆蛋白A预测再发急性冠脉综合征的临床价值[J].医学信息,2019,32(08):173.[doi:10.3969/j.issn.1006-1959.2019.08.055]
　TAN Zi-ming,YE Huai-kuo,et al.Clinical Value of High-sensitivity C-reactive Protein and Pregnancy-associated Plasma Protein A in Predicting Recurrent Acute Coronary Syndrome[J].Medical Information,2019,32(01):173.[doi:10.3969/j.issn.1006-1959.2019.08.055]
[3]梁道博,姚卜飞,夏双燕.氯吡格雷联合阿司匹林治疗急性冠脉综合征疗效与 安全性的Meta分析[J].医学信息,2019,32(11):76.[doi:10.3969/j.issn.1006-1959.2019.11.021]
　LIANG Dao-bo,YAO Bu-fei,XIA Shuang-yan.Meta-analysis of the Efficacy and Safety of Clopidogrel Combined with Aspirin in the Treatment of Acute Coronary Syndrome[J].Medical Information,2019,32(01):76.[doi:10.3969/j.issn.1006-1959.2019.11.021]
[4]张牧秋,古俊楠,刘 瑜,等.NOACS治疗房颤合并急性冠脉综合征的研究[J].医学信息,2019,32(13):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
　ZHANG Mu-qiu,GU Jun-nan,LIU Yu,et al.Study of NOACS in the Treatment of Atrial Fibrillation Complicated with Acute Coronary Syndrome[J].Medical Information,2019,32(01):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
[5]王建强,刘 瑜,张牧秋,等.房颤伴ACS患者经皮冠状动脉介入术后抗栓研究[J].医学信息,2019,32(14):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
　WANG Jian-qiang,LIU Yu,ZHANG Mu-qiu,et al.Study on Antithrombotic after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and ACS[J].Medical Information,2019,32(01):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
[6]蒲 丹.宫颈癌前病变组织中Galectin-3和P27 kip1蛋白的表达与临床预后的关系[J].医学信息,2022,35(17):31.[doi:10.3969/j.issn.1006-1959.2022.17.007]
　PU Dan.Expression of Galectin-3 and P27kip1 in Cervical Precancerous Lesions and its Relationship with Clinical Prognosis[J].Medical Information,2022,35(01):31.[doi:10.3969/j.issn.1006-1959.2022.17.007]
[7]孙 洋,高 山,宋 京,等.血尿酸、同型半胱氨酸、脑钠肽、肌钙蛋白Ⅰ与急性冠脉综合征病变程度的相关性[J].医学信息,2020,33(02):105.[doi:10.3969/j.issn.1006-1959.2020.02.028]
　SUN Yang,GAO Shan,SONG Jing,et al.Correlation Between Serum Uric Acid,Homocysteine,Brain Natriuretic Peptide,TroponinⅠ and the Severity of Acute Coronary Syndrome[J].Medical Information,2020,33(01):105.[doi:10.3969/j.issn.1006-1959.2020.02.028]
[8]史作霞,张文彦,李 馨,等.改良桡动脉止血器在老年ACS患者动脉穿刺后压迫止血中的效果[J].医学信息,2020,33(02):184.[doi:10.3969/j.issn.1006-1959.2020.02.060]
　SHI Zuo-xia,ZHANG Wen-yan,LI Xin,et al.Evaluation of Improved Radial Arterial Hemostatic Device in Compression Hemostasis After Arterial Puncture in Elderly Patients with ACS[J].Medical Information,2020,33(01):184.[doi:10.3969/j.issn.1006-1959.2020.02.060]
[9]董 谦,陈 康,王伟佳.多重指标在急性冠脉综合症中的应用价值[J].医学信息,2021,34(05):172.[doi:10.3969/j.issn.1006-1959.2021.05.050]
　DONG Qian,CHEN Kang,WANG Wei-jia.The Application Value of Multiple Indexes in Acute Coronary Syndrome[J].Medical Information,2021,34(01):172.[doi:10.3969/j.issn.1006-1959.2021.05.050]
[10]王 楠.血栓通注射液对急性冠脉综合征介入治疗后血脂、炎症因子及内皮功能的影响[J].医学信息,2021,34(09):122.[doi:10.3969/j.issn.1006-1959.2021.09.032]
　WANG Nan.Effect of Xueshuantong Injection on Blood Lipid,Inflammatory Factors and Endothelial Function After Interventional Therapy for Acute Coronary Syndrome[J].Medical Information,2021,34(01):122.[doi:10.3969/j.issn.1006-1959.2021.09.032]

更新日期/Last Update: 1900-01-01